In QuotedData’s morning briefing 18 May 2021:
- Syncona highlights results from one of its holdings – Freeline. Its chief executive says they are encouraged by the progress seen in patient identification and screening in its FLT190 Phase 1/2 dose-finding trial for the treatment of Fabry disease; they are advancing their FLT201 programme for the treatment of Gaucher disease Type 1 into the clinic, in a Phase 1/2 dose-finding study, which they plan to initiate by year-end; and their FLT180a programme for the treatment of Hemophilia B continues to progress and they will initiate the dose-confirmation trial later this year.
- Fitch Ratings has published its first credit rating for Sirius Real Estate, resulting in a BBB rating with a stable outlook (Long-Term Issuer Default Rating).
- Trian Investors 1, the vehicle set up by Nelson Peltz, Ed Garden and Peter W. May to invest in Ferguson plc, wants to buy back up to $20m of its shares, explore other opportunities and introduce an incentive scheme for its managers. In addition, Trian Investors 1 Subscriber, LLC, a company owned by Trian’s partners and their affiliates, will buy up to a additional $10m worth of Trian Investors 1’s shares – the aim is to reduce the discount. A proposed change to its investment objective would also allow the company to take control of its investments – converting it into something more like a special purpose acquisition company (SPAC).
- Highbridge Tactical Credit will return £14,682,460.96 (equivalent to 83p per share) to shareholders on 20 May 2021, by way of a compulsory partial redemption of ordinary shares.
We also have news of acquisitions by JLEN Environmental and Warehouse REIT and interim results from Tritax EuroBox.
